Close Menu
Dailyza | Tech, Investments, Business & World News
  • Startups
  • Venture Capital
  • World
  • Economy
  • Politics
  • Science
  • Technology
  • Travel
  • Culture
Facebook X (Twitter) Instagram
Trending
  • Orcan Energy targets AI data centers with waste-heat power
  • Donald Trump Ousts Pam Bondi Over Epstein Files and Rival Probes
  • Monzo exits US market to double down on Europe and IPO bid
  • Jake Paul’s Anti Fund bets on attention as a VC edge
  • Brilliance secures €6M to advance integrated RGB laser chips
  • Wearable Robotics secures €5M to advance rehab exoskeletons
  • Paysend secures $25M to speed up global money transfers
  • SMEY unveils Lipid Atlas, an AI platform for lipidomics
Dailyza | Tech, Investments, Business & World NewsDailyza | Tech, Investments, Business & World News
Saturday, April 4
  • Startups
  • Venture Capital
  • World
  • Economy
  • Politics
  • Science
  • Technology
  • Travel
  • Culture
Dailyza | Tech, Investments, Business & World News
Home»Venture Capital
Former OpenAI and DeepMind researchers discussing plans to build autonomous AI scientist systems in a modern research lab

Former OpenAI team targets $7B to build AI scientists

26 March 2026 Venture Capital No Comments2 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

Ex-OpenAI and DeepMind talent chase $7B for AI scientists

A new wave of ambition is sweeping through the artificial intelligence sector as a group of former OpenAI and DeepMind researchers seek a valuation of around $7 billion for a startup focused on building autonomous AI scientists. The company, whose name has not yet been publicly disclosed, is positioning itself at the frontier of using AI models to design, run and interpret complex scientific experiments with minimal human oversight.

From large language models to autonomous discovery

The team’s vision goes beyond today’s generative AI and large language models. Instead of merely assisting with drafting papers or writing code, these proposed AI scientists would be tasked with formulating hypotheses, planning experiments, running simulations, and even controlling laboratory equipment through integrated software and robotics.

Backers are said to be attracted by the prospect of dramatically accelerating research in fields such as drug discovery, materials science and climate modelling. By combining advanced AI algorithms with automated labs, the startup aims to compress years of trial-and-error into weeks or days, potentially reshaping how fundamental science and industrial R&D are conducted.

Investors weigh promise against safety concerns

The search for a $7 billion valuation at an early stage underlines how aggressively capital is chasing the next generation of AI infrastructure. Venture firms and strategic investors view autonomous scientific systems as a potential platform play, comparable in importance to the first wave of cloud computing or foundation models.

However, the concept of machine-led discovery is also raising questions about AI safety, governance and reproducibility. Critics warn that delegating more of the scientific process to opaque models could make it harder to audit results or understand how key breakthroughs were reached. Supporters counter that rigorous validation pipelines, transparent data practices and human-in-the-loop review can keep systems accountable while still delivering unprecedented speed.

A new race in AI-native science platforms

If the raise is successful, the startup would instantly join the top tier of privately held AI companies by valuation and intensify competition with existing players building automated labs and scientific copilots. For now, the move signals that the next battleground in advanced artificial intelligence may be less about chatbots and more about who can industrialise scientific discovery itself.

Previous ArticleSOUS secures €4M to bring AI growth tools to indie F&B
Next Article Shield AI Secures $2B from Advent to Scale Hivemind Platform
Kenyon Shah
  • Website

Keep Reading

Jake Paul’s Anti Fund bets on attention as a VC edge

Barclays backs £130M ‘Women Backing Women’ VC fund push

European startups secure fresh capital in early April surge

Generare secures €20M from Alven, Daphni to turbocharge drug R&D

Rupa Popat on Arāya Ventures and the Future of Impact VC

Generare raises €20M to decode microbial genomes for drugs

Add A Comment

Leave A Reply Cancel Reply

Jake Paul’s Anti Fund bets on attention as a VC edge

Venture Capital 3 April 2026

Anti Fund, co-founded by Jake Paul, is pitching a new venture model built on attention, disciplined execution and long-term trust, not celebrity hype.

SMEY unveils Lipid Atlas, an AI platform for lipidomics

Barclays backs £130M ‘Women Backing Women’ VC fund push

European startups secure fresh capital in early April surge

Generare secures €20M from Alven, Daphni to turbocharge drug R&D

Rupa Popat on Arāya Ventures and the Future of Impact VC

Generare raises €20M to decode microbial genomes for drugs

British Business Bank Unites Major Investors in New Fund

Runway Fund backs early AI and media startups worldwide

Connectome secures $2M to detect silent brain decline early

Kleiner Perkins Backs Saronic in $1.75B Bet on US Autonomy

MOVEMENTS secures €300k pre-seed to power values-led campaigns

EU-Startups Summit 2026 unveils leading space innovators

Metafuels wins €1.92M Dutch grant for Rotterdam e-SAF plant

Alice & Bob wins €3.4M ARPA-E grant for quantum magnets

Dailyza | Tech, Investments, Business & World News
  • Startups
  • Contact
  • About Us
© 2026 Dailyza

Type above and press Enter to search. Press Esc to cancel.